June 22 2022 Acip Meeting Public Comment

Summary

Introduction; Vaccine effectiveness update; Influenza vaccination of older adults; Summary, work group considerations, and ... Introduction; EtR and proposed recommendations. Introduction; RSV virion & vaccine products; Epidemiology of RSV in children; Epidemiology of RSV in adults; Safety and efficacy ... Introduction; PCV15 Pediatric Clinical Development Program – Update; Economic analysis and Introduction; National and state-level HPV vaccination coverage; Impact of the US HPV vaccination program on HPV-associated ... Influenza Vaccine; Pneumococcal Vaccines; Pneumococcal Vaccines; MMR Vaccine. Introduction; Economic analysis of RSVpreF in pediatric populations; EtR Pfizer maternal RSV vaccine; Economic analysis of ... Updates to the EtR Framework: Pfizer-BioNTech COVID-19 vaccine; booster doses in adolescents 12-15 years of age; VOTE: ... Safety, immunogenicity and efficacy of BNT162b2 in children ages 6 months through 4 years of age; mRNA COVID-19 vaccines in ... Introduction; Plan for revisiting adolescent schedule for meningococcal vaccines; Comparison of Pfizer and CDC cost ... Introduction; RSVpreF Vaccine Safety Surveillance in Pregnancy from The Vaccine Safety Datalink ;Maternal RSV vaccine safety ... Influenza activity update; Recommending enhanced seasonal influenza vaccines in adults age 65 and older--potential impacts on ... Epidemiology of pneumococcal disease and pneumococcal vaccine coverage in US children; PCV15 Phase 2/3 study results in ...